tiprankstipranks
Structure Therapeutics, Inc. Sponsored ADR (GPCR)
NASDAQ:GPCR
US Market

Structure Therapeutics, Inc. Sponsored ADR (GPCR) Financial Statements

153 Followers

Structure Therapeutics, Inc. Sponsored ADR Financial Overview

Structure Therapeutics, Inc. Sponsored ADR's market cap is currently ―. The company's EPS TTM is $-2.507; its P/E ratio is -15.53; Structure Therapeutics, Inc. Sponsored ADR is scheduled to report earnings on May 9, 2024, and the estimated EPS forecast is $-0.21. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Sep 23Jun 23Mar 23Dec 22
Income Statement-
Total Revenue----$ 0.00
Gross Profit-----
EBIT$ -24.82M$ -23.46M$ -23.16M$ -17.95M$ -12.96M
EBITDA$ -24.74M$ -23.38M$ -23.09M$ -17.88M$ -12.88M
Net Income Common Stockholders$ -24.50M$ -23.86M$ -23.28M$ -17.98M$ -11.88M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 467.32M$ 205.42M$ 224.59M$ 240.86M$ 90.84M
Total Assets$ 482.02M$ 216.37M$ 229.43M$ 246.39M$ 97.84M
Total Debt$ 5.45M$ 3.85M$ 73.00K$ 168.00K$ 260.00K
Net Debt$ -461.87M$ -201.57M$ -224.51M$ -240.69M$ -90.58M
Total Liabilities$ 29.05M$ 23.41M$ 15.01M$ 11.00M$ 212.99M
Stockholders Equity$ 452.97M$ 192.96M$ 214.41M$ 236.35M$ -115.14M
Cash Flow-
Free Cash Flow$ -22.89M$ -21.38M$ -17.09M$ -20.31M$ -12.10M
Operating Cash Flow$ -21.73M$ -20.56M$ -16.89M$ -20.31M$ -12.03M
Investing Cash Flow$ -180.74M$ 30.13M$ -68.71M$ -49.02M$ 10.34M
Financing Cash Flow$ 281.63M$ 473.00K$ -297.00K$ 169.73M$ -316.00K
Currency in USD

Structure Therapeutics, Inc. Sponsored ADR Earnings and Revenue History

Structure Therapeutics, Inc. Sponsored ADR Debt to Assets

Structure Therapeutics, Inc. Sponsored ADR Cash Flow

Structure Therapeutics, Inc. Sponsored ADR Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis